• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TR47是一种基于PAR1的肽,可在体外抑制黑色素瘤细胞迁移,并在体内抑制其转移。

TR47, a PAR1-based peptide, inhibits melanoma cell migration in vitro and metastasis in vivo.

作者信息

de Oliveira Andreia S, de Almeida Vitor H, Gomes Fausto G, Rezaie Alireza R, Monteiro Robson Q

机构信息

Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.

出版信息

Biochem Biophys Res Commun. 2018 Jan 1;495(1):1300-1304. doi: 10.1016/j.bbrc.2017.11.174. Epub 2017 Nov 28.

DOI:10.1016/j.bbrc.2017.11.174
PMID:29196264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5752140/
Abstract

Activated Protein C (APC) is a serine-protease that displays antithrombotic and anti-inflammatory properties. In addition, cleavage of protease-activated receptor 1 (PAR1) by APC exerts endothelial cytoprotective actions. The effects of APC on endothelial cells may be reproduced by TR47, a PAR1-based peptide that mimics the novel N-terminus of PAR1 generated upon cleavage at Arg-46 by APC. In this study we demonstrate that wild-type APC and its signaling-proficient mutant, APC-2Cys (which has dramatically reduced anticoagulant activity), display similar inhibitory effects towards the transendothelial migration of A375 human melanoma cells. Consistent with this observation, APC and APC-2Cys significantly reduced the in vivo metastatic potential of the B16F10 murine melanoma cells. TR47 recapitulated the in vitro and in vivo protective profiles of APC and APC-2Cys. Treatment of EA.hy926 endothelial cells with TR47 (20 μM) significantly decreased the A375 cell migration. In addition, treatment of C57/BL6 mice with a single TR47 dose (125 μg/animal) strongly reduced the metastatic burden of B16F10 cells. Together, our results suggest that protection of the endothelial barrier by APC/TR47-mediated signaling pathways might be a valuable therapeutic approach to prevent metastasis.

摘要

活化蛋白C(APC)是一种具有抗血栓形成和抗炎特性的丝氨酸蛋白酶。此外,APC对蛋白酶激活受体1(PAR1)的切割发挥内皮细胞保护作用。APC对内皮细胞的作用可由TR47重现,TR47是一种基于PAR1的肽,可模拟APC在Arg-46处切割后产生的PAR1新N端。在本研究中,我们证明野生型APC及其信号传导功能正常的突变体APC-2Cys(其抗凝活性显著降低)对A375人黑色素瘤细胞的跨内皮迁移表现出相似的抑制作用。与该观察结果一致,APC和APC-2Cys显著降低了B16F10小鼠黑色素瘤细胞的体内转移潜能。TR47重现了APC和APC-2Cys的体外和体内保护作用。用TR47(20 μM)处理EA.hy926内皮细胞可显著降低A375细胞迁移。此外,用单一剂量的TR47(125 μg/动物)处理C57/BL6小鼠可强烈降低B16F10细胞的转移负担。总之,我们的结果表明,通过APC/TR47介导的信号通路保护内皮屏障可能是预防转移的一种有价值的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2878/5752140/451ffbed111d/nihms923214f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2878/5752140/bb8306bca6bd/nihms923214f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2878/5752140/65588483e6d9/nihms923214f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2878/5752140/451ffbed111d/nihms923214f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2878/5752140/bb8306bca6bd/nihms923214f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2878/5752140/65588483e6d9/nihms923214f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2878/5752140/451ffbed111d/nihms923214f3.jpg

相似文献

1
TR47, a PAR1-based peptide, inhibits melanoma cell migration in vitro and metastasis in vivo.TR47是一种基于PAR1的肽,可在体外抑制黑色素瘤细胞迁移,并在体内抑制其转移。
Biochem Biophys Res Commun. 2018 Jan 1;495(1):1300-1304. doi: 10.1016/j.bbrc.2017.11.174. Epub 2017 Nov 28.
2
Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.激活蛋白 C 通过非典型切割精氨酸 46 导致蛋白酶激活受体 1 的偏性激动。
Blood. 2012 Dec 20;120(26):5237-46. doi: 10.1182/blood-2012-08-452169. Epub 2012 Nov 13.
3
An orthosteric/allosteric bivalent peptide agonist comprising covalently linked protease-activated receptor-derived peptides mimics in vitro and in vivo activities of activated protein C.一种包含共价连接的蛋白酶激活受体衍生肽的正变/变构二价肽激动剂,模拟活化蛋白 C 的体外和体内活性。
J Thromb Haemost. 2024 Jul;22(7):2039-2051. doi: 10.1016/j.jtha.2024.04.007. Epub 2024 Apr 24.
4
Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.蛋白酶激活受体(PAR1和PAR2)有助于肿瘤细胞的运动和转移。
Mol Cancer Res. 2004 Jul;2(7):395-402.
5
Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1.在小鼠模型中,活化蛋白C对血管屏障完整性的保护作用取决于蛋白酶激活受体-1。
Thromb Haemost. 2009 Apr;101(4):724-33. doi: 10.1160/th08-10-0632.
6
[Peptide-agonist of protease-activated receptor (PAR 1), similar to activated protein C, promotes proliferation in keratinocytes and wound healing of epithelial layer].[蛋白酶激活受体(PAR 1)的肽激动剂,类似于活化蛋白C,可促进角质形成细胞增殖和上皮层伤口愈合]
Biomed Khim. 2014 Nov-Dec;60(6):702-6. doi: 10.18097/pbmc20146006702.
7
Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.蛋白酶激活受体1与血小板活化因子受体之间的相互作用调节黑色素瘤细胞粘附分子(MCAM/MUC18)的表达及黑色素瘤转移。
J Biol Chem. 2009 Oct 16;284(42):28845-55. doi: 10.1074/jbc.M109.042150. Epub 2009 Aug 24.
8
Activated protein C ameliorates chronic graft-versus-host disease by PAR1-dependent biased cell signaling on T cells.活化蛋白 C 通过 PAR1 依赖性偏倚的 T 细胞信号转导改善慢性移植物抗宿主病。
Blood. 2019 Aug 29;134(9):776-781. doi: 10.1182/blood.2019001259. Epub 2019 Jun 26.
9
Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin.即使在存在凝血酶的情况下,活化蛋白C切割的蛋白酶活化受体-1仍保留在内皮细胞表面。
Blood. 2008 Mar 1;111(5):2667-73. doi: 10.1182/blood-2007-09-113076. Epub 2007 Dec 18.
10
Activated protein C signals through the thrombin receptor PAR1 in endothelial cells.活化蛋白C通过内皮细胞中的凝血酶受体PAR1发出信号。
J Endotoxin Res. 2003;9(5):317-21. doi: 10.1179/096805103225002584.

引用本文的文献

1
Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis.内皮蛋白C受体:类风湿关节炎病理生理学中的多功能介质
Cells. 2025 Mar 24;14(7):485. doi: 10.3390/cells14070485.
2
Lactoferrin and Activated Protein C: Potential Role in Prevention of Cancer Progression and Recurrence.乳铁蛋白与活化蛋白C:在预防癌症进展和复发中的潜在作用
Int J Mol Cell Med. 2023;12(1):86-99. doi: 10.22088/IJMCM.BUMS.12.1.86.
3
Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis.黑色素瘤发生、侵袭和转移的遗传及基因组通路

本文引用的文献

1
Preclinical mouse solid tumour models: status quo, challenges and perspectives.临床前小鼠实体瘤模型:现状、挑战和展望。
Nat Rev Cancer. 2017 Dec;17(12):751-765. doi: 10.1038/nrc.2017.92. Epub 2017 Oct 27.
2
Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms.乳腺癌细胞外囊泡通过组织因子非依赖和依赖的机制诱导血小板的激活和聚集。
Thromb Res. 2017 Nov;159:24-32. doi: 10.1016/j.thromres.2017.09.019. Epub 2017 Sep 21.
3
Thrombomodulin modulates cell migration in human melanoma cell lines.
Genes (Basel). 2021 Sep 28;12(10):1543. doi: 10.3390/genes12101543.
4
Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead.嵌合抗原受体 (CAR) T 细胞疗法治疗转移性黑色素瘤:挑战与展望。
Cells. 2021 Jun 9;10(6):1450. doi: 10.3390/cells10061450.
5
Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation.使用PAR-1拮抗剂治疗中风以减少出血性转化。
Front Neurol. 2021 Mar 15;12:593582. doi: 10.3389/fneur.2021.593582. eCollection 2021.
6
Activated protein C and PAR1-derived and PAR3-derived peptides are anti-inflammatory by suppressing macrophage NLRP3 inflammasomes.活化蛋白 C 及 PAR1 衍生肽和 PAR3 衍生肽通过抑制巨噬细胞 NLRP3 炎性小体发挥抗炎作用。
J Thromb Haemost. 2021 Jan;19(1):269-280. doi: 10.1111/jth.15133. Epub 2020 Dec 7.
7
Activated protein C in neuroprotection and malaria.活化蛋白 C 在神经保护和疟疾中的作用。
Curr Opin Hematol. 2019 Sep;26(5):320-330. doi: 10.1097/MOH.0000000000000528.
8
Endothelial Protein C Receptor (EPCR), Protease Activated Receptor-1 (PAR-1) and Their Interplay in Cancer Growth and Metastatic Dissemination.内皮细胞蛋白C受体(EPCR)、蛋白酶激活受体-1(PAR-1)及其在癌症生长和转移扩散中的相互作用
Cancers (Basel). 2019 Jan 8;11(1):51. doi: 10.3390/cancers11010051.
血栓调节蛋白调节人黑色素瘤细胞系的细胞迁移。
Melanoma Res. 2014 Feb;24(1):11-9. doi: 10.1097/CMR.0000000000000035.
4
Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.偏向性信号传导与蛋白酶激活受体(PARs):针对炎症性疾病的研究
Br J Pharmacol. 2014 Mar;171(5):1180-94. doi: 10.1111/bph.12544.
5
Crossing the endothelial barrier during metastasis.在转移过程中穿过内皮屏障。
Nat Rev Cancer. 2013 Dec;13(12):858-70. doi: 10.1038/nrc3628.
6
Activation of blood coagulation in cancer: implications for tumour progression.癌症中血液凝固的激活:对肿瘤进展的影响。
Biosci Rep. 2013 Sep 4;33(5):e00064. doi: 10.1042/BSR20130057.
7
Coagulation and metastasis: what does the experimental literature tell us?凝血与转移:实验文献告诉了我们什么?
Br J Haematol. 2013 Aug;162(4):433-41. doi: 10.1111/bjh.12381. Epub 2013 May 21.
8
Endothelial protein C receptor function in murine and human breast cancer development.内皮蛋白 C 受体在鼠类和人类乳腺癌发展中的作用。
PLoS One. 2013 Apr 9;8(4):e61071. doi: 10.1371/journal.pone.0061071. Print 2013.
9
Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.激活蛋白 C 通过非典型切割精氨酸 46 导致蛋白酶激活受体 1 的偏性激动。
Blood. 2012 Dec 20;120(26):5237-46. doi: 10.1182/blood-2012-08-452169. Epub 2012 Nov 13.
10
Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects.蛋白酶激活受体-1 在 R46 位点被切割介导细胞保护作用。
J Thromb Haemost. 2012 Aug;10(8):1675-84. doi: 10.1111/j.1538-7836.2012.04825.x.